MYX 0.66% $4.60 mayne pharma group limited

Ann: 2022 Full Year Media Release, page-6

  1. 825 Posts.
    lightbulb Created with Sketch. 1146
    I thought this is not so bad?
    They have the other part moving quickly, like E4 uptake is going rapidly now and the Demotology is growing fast. Now selling out the slow growing one, the contract service only grew 10-ish%.

    Overall, this should be a turn point?
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.